<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01538160</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-11-8657-OS-CTIL</org_study_id>
    <nct_id>NCT01538160</nct_id>
  </id_info>
  <brief_title>A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery</brief_title>
  <acronym>rFVIIa</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lately the investigators found that patients with severe factor XI deficiency and inhibitors
      could undergo major surgery with a single low dose of recombinant factor VIIa and tranexamic
      agent. These results encourage us to apply this treatment in clinical trial setting to
      patients with severe factor XI deficiency undergoing surgery instead of blood product.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients will be those with severe factor XI deficiency who agree to participate in
      the study . The treatment does not apply to patients requiring coronary artery bypass or
      other vascular surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in prophylactic treatment by using single and low dose recombinant FVIIa in patients with severe FXI deficiency</measure>
    <time_frame>1 week</time_frame>
    <description>End point to be assessed the degree of bleeding following major operation under rFVIIa</description>
  </primary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Hemophilia C</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>recombinant factor VIIa</intervention_name>
    <description>single dose of 20ug/kg of recombinant factor VIIa along with tranexamic acid of 4 gram a day for 7 days following surgery</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with severe factor XI deficiency who will give informed consent to
             participate in the study

        Exclusion Criteria:

          -  patients with atherosclerosis disease i.e. unstable angina pectoris or recent stroke

          -  Patients who required aorto-coronary bypass or any vascular surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ophira Salomon, MD</last_name>
    <phone>97235302104</phone>
    <email>ophiras@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Uri Seligsohn, MD</last_name>
    <phone>97235302104</phone>
    <email>Uri.Seligson@sheba.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ophira Salomon</name>
      <address>
        <city>Ramat -Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ophira salomon, MD</last_name>
      <phone>01197235302104</phone>
      <email>ophiras@sheba.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Uri Seligsohn, MD</last_name>
      <phone>01197235302104</phone>
      <email>Uri.Seligson@sheba.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Uri Seligsohn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ophira Salomon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer, Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Salomon et al presented at ASH 2008 entitled</citation>
  </reference>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2012</study_first_submitted>
  <study_first_submitted_qc>February 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2012</study_first_posted>
  <last_update_submitted>February 22, 2012</last_update_submitted>
  <last_update_submitted_qc>February 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recombinant factor VIIa</keyword>
  <keyword>factor XI deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Factor XI Deficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

